HIV JournalView
No Excess Death Among HIV-Infected People -- as Long as CD4+ Cell Counts Are Kept Close to Normal (March 15, 2013)
A new study gives us the most conclusive evidence to date that HIV-positive people who take their meds and keep their CD4 count above 500 are just as healthy overall as HIV-negative people.
In HIV JournalView, from TheBodyPRO.com
Dangers of Smoking Greatly Enhanced for HIV-Infected Patients, Study Finds (February 21, 2013)
A recently published study from a national cohort of HIV-infected Danes supplies a bunch of new facts that you can use to scare -- er, counsel -- your patients afflicted with tobaccoism.
In HIV JournalView, from TheBodyPRO.com
Top 10 HIV Clinical Developments of 2012 (December 2012)
In HIV JournalView, from TheBodyPRO.com
HIV JournalView: October/November 2012 (November 27, 2012)
David Alain Wohl, M.D., looks at new findings regarding racial disparities in HIV care, predicting hospital readmissions, sexual transmission of HCV, treatment of diabetes, and more accurate/efficient ways to measure and predict adherence.
In HIV JournalView, from TheBodyPRO.com
HIV JournalView: September 2012 (October 15, 2012)
David Alain Wohl, M.D., explores recently published findings regarding access to HIV care in the U.S., the impact of pain on clinic no-shows, links between atazanavir and gall/kidney stones, anal sex and HIV among women, and the limits of echocardiography.
In HIV JournalView, from TheBodyPRO.com
- HIV JournalView (October/November 2007)
Breaking research on malignancies, metabolic complications, darunavir resistance, sperm washing and more -- concise analysis from David Wohl, M.D.
In HIV JournalView, from TheBodyPRO.com
- HIV JournalView (September 2007)
Among other reviews this month, David Wohl, M.D., looks at the latest studies on entecavir and HIV drug resistance and examines how saturated fat intake contributes to HIV-associated hypertriglyceridemia.
In HIV JournalView, from TheBodyPRO.com
- HIV JournalView (July 2007)
Among other stories this month, Graeme Moyle, M.D., reviews the potential for shifting HIV tropism and what this means to the use of CCR5 antagonists.
In HIV JournalView, from TheBodyPRO.com
- Top 10 HIV Medical Stories of 2006 (February 2007)
It's one of the most insightful, entertaining, informative HIV research recaps you'll read this year: The Body PRO's David Wohl, M.D., presents an end-of-year review of the developments that made the biggest waves among HIV health care professionals in 2006. If you're looking for an easy-to-digest recap of the most critical news in HIV over the last calendar year, this is the article to read.
In HIV JournalView, from TheBodyPRO.com
- HIV JournalView (September/October 2006)
Pablo Tebas, M.D., analyzes recently published research on: the utility (or lack thereof) of viral load tests in predicting the rate of CD4+ cell decline; the tendency for HIV-infected patients to have a poorer prognosis when diagnosed with lung cancer than their HIV-uninfected counterparts; the potential for drug interactions between enfuvirtide and ritonavir-boosted tipranavir; and the high prevalence of human papillomavirus infection among sexually active men.
To read PDF, click here.
In HIV JournalView, from TheBodyPRO.com
VIEW ALL ARTICLES
|
Advertisement
|